The Rac1 GEF, DOCK1, is a potential therapeutic target for macropinocytosis in tumours with Rac1P29S mutation, as its inhibition caused a decrease in invasion and macropinocytosis of both melanoma and breast cancer cells harbouring Rac1P29S mutations 79. This evidence concerns the gene RAC1 and melanoma.